Uriach plans to acquire Laboratoires Ineldea, enhancing its position in the European natural health market and leveraging synergies for future growth.
Information on the Target
Uriach has initiated plans to acquire Laboratoires Ineldea, a prominent French company specializing in natural self-care products. Founded in 2003 by Nicolas Cappelaere, Ineldea has established itself as a key player in the formulation, development, and distribution of natural health products catering to all demographics. The company has formed strong partnerships with approximately 5,000 pharmacies and 7,700 prescribers in France, in addition to having 80 export distributors globally.
Ineldea is recognized for its commitment to crafting effective and safe products derived from high-quality natural ingredients, which have garnered positive acclaim from healthcare professionals. With an annual turnover nearing 100 million euros and a team of 230 employees, the company boasts a diverse portfolio of successful natural health products, including leading brands such as PEDIAKID for pediatric care and OLIOSEPTIL for essential oils.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in France
The natural health product industry in France has seen significant growth, driven by a rising consumer preference for natural and holistic healthcare solutions. As awareness about
Similar Deals
FrenchFood Capital → SOPHIE LEBREUILLY
2025
FrenchFood Capital → JC David, Plantin, Huguenin
2024
Groupement Mousquetaires → Groupe Casino
2024
Uriach
invested in
Laboratoires Ineldea
in 2024
in a Other Private Equity deal
Disclosed details
Revenue: $100M